Organization
Immunomedics Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Immunomedics Inc.
... Immunomedics to Fund Phase 2 Study Sponsored by the University of Wisconsin to ...
... Across All Indications for $175 Million Royalty Pharma Acquires $75 Million of Immunomedics Common Stock at $17.15 per share, a More Than 15% Premium over ...
... MORRIS PLAINS, N.J., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (NASDAQ:IMMU) ("Immunomedics" or the "Company") today announced that Michael Pehl, President and ...
... investment community. Today we are offering reports on AUPH, ALDR, AKAO, and IMMU which can be accessed for free by signing up tohttp://www.wallstequities.com/registration. On Friday, ...
... with current developments include: Lexington Biosciences, Inc. (CSE: LNB) (OTC: LXGTF), Immunomedics Inc. (NASDAQ: IMMU), Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), BioTelemetry Inc. (NASDAQ: BEAT), VistaGen ...
... SAN ANTONIO, Dec. 06, 2017 (GLOBE NEWSWIRE) -- Â Immunomedics, Inc. (NASDAQ:IMMU) ("Immunomedics" or the "Company") today announced that a blinded, independent review by an ...
... have been filed in last decade alone. ImmmunoGen, Genentech, Seattle Genetics and Immunomedics were the first to enter this domain, and currently have the highest ...
... AT&T Inc. (NYSE:T), Denbury Resources Inc. (NYSE:DNR), Novavax, Inc. (NASDAQ:NVAX), and Immunomedics, Inc. (NASDAQ:IMMU), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst ...
... MORRIS PLAINS, N.J., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) ("Immunomedics" or the "Company") today announced that two of its abstracts ...
... Immunomedics has drawn a firm line under the disruption among its top management ...
... oncology on Aug. 21, 2017. Now, he has been chosen to lead Immunomedics, whose lead candidate, antibody-drug conjugate IMMU-132, awaits submission for approval in breast ...
... the Proxy Contest MORRIS PLAINS, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) ("Immunomedics" or the "Company") today reported financial results for the ...
... MORRIS PLAINS, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (NASDAQ:IMMU) ("Immunomedics" or the "Company") today announced that its Board of Directors ...
... MORRIS PLAINS, N.J., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) ("Immunomedics" or the "Company") today announced that it will host a ...
... If you want a Stock Review on CNAT, IMMU, INSY, or NVIV then come over tohttp://dailystocktracker.com/register/and sign up for your free ...
... (ESMO) 2017 Congress MADRID, Spain, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) ("Immunomedics" or the "Company") today announced that sacituzumab govitecan (IMMU-132) is ...
... MORRIS PLAINS, N.J., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) ("Immunomedics" or the "Company") today announced that the Company will present ...
... MORRIS PLAINS, N.J., Aug. 21, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) ("Immunomedics" or the "Company") today announced that labetuzumab govitecan (IMMU-130), the ...
... MORRIS PLAINS, N.J., Aug. 16, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) ("Immunomedics" or the "Company") today reported financial results for the fourth ...
... MORRIS PLAINS, N.J., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) ("Immunomedics" or the "Company") today announced that it will report financial ...
... If you want a Stock Review on OPK, ARRY, IMMU, or TGTX then come over tohttp://dailystocktracker.com/register/and sign up for your free customized ...
... Clinical Oncology MORRIS PLAINS, N.J., July 10, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (NASDAQ:IMMU) ("Immunomedics" or the "Company") today reported the publication in two prominent ...
Want to see the full history on Immunomedics Inc.? Upgrade to RelSci Pro now!
Start My Free Trial